SMARCB1 and rhabdoid tumor: We demonstrate that re-expression of SMARCB1 increases rhabdoid tumor cells’ viability in the presence of a range of concentrations of HHT (Fig. S1, B–E and Fig. 1, A–D, red lines), while expression of GFP does not (Fig. 1, A–D, black lines).